Jiya Acquisition Corp. (JYAC)
Price:
10.04 USD
( - 0 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Churchill Capital Corp X
VALUE SCORE:
7
2nd position
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
The best
Horizon Kinetics SPAC Active ETF
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Jiya Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the biopharmaceutical sector. Jiya Acquisition Corp. was incorporated in 2020 and is based in Palo Alto, California.
NEWS
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
Jiya Acquisition Corp. Announces Pricing Of $100 Million Initial Public Offering
prnewswire.com
2020-11-18 19:29:00PALO ALTO, Calif., Nov. 18, 2020 /PRNewswire/ -- Jiya Acquisition Corp. (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more...
No data to display
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
Jiya Acquisition Corp. Announces Pricing Of $100 Million Initial Public Offering
prnewswire.com
2020-11-18 19:29:00PALO ALTO, Calif., Nov. 18, 2020 /PRNewswire/ -- Jiya Acquisition Corp. (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more...